Literature DB >> 8338938

Chronic myelogenous leukemia: a concise update.

H M Kantarjian1, A Deisseroth, R Kurzrock, Z Estrov, M Talpaz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338938

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  40 in total

Review 1.  Monitoring the course of chronic myelogenous leukemia by fluorescence in situ hybridization.

Authors:  Chu-Myong Seong
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  The study of minimal residual disease in acute lymphoblastic leukaemia.

Authors:  C J Knechtli; N J Goulden; K Langlands; M N Potter
Journal:  Clin Mol Pathol       Date:  1995-04

3.  A Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia.

Authors:  Ankur Jain; Naresh Gupta; Tejinder Singh; Sunita Agarwal
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 4.  Autografting as first line treatment for chronic myeloid leukaemia.

Authors:  I O Singer; I M Franklin
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

Review 5.  Interferon-alpha in childhood haematological malignancies.

Authors:  R Simkó; K Nagy
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

6.  hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.

Authors:  Angela Iervolino; Giorgia Santilli; Rossana Trotta; Clara Guerzoni; Vincenzo Cesi; Anna Bergamaschi; Carlo Gambacorti-Passerini; Bruno Calabretta; Danilo Perrotti
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

7.  Establishment and characterization of A novel Philadelphia-chromosome positive chronic myeloid leukemia cell line, TCC-S, expressing P210 and P190 BCR/ABL transcripts but missing normal ABL gene.

Authors:  Phan Nguyen Thanh Van; Phan Thi Xinh; Yasuhiko Kano; Katsushi Tokunaga; Yuko Sato
Journal:  Hum Cell       Date:  2005-03       Impact factor: 4.174

Review 8.  Tyrosine kinase inhibition: a therapeutic target for the management of chronic-phase chronic myeloid leukemia.

Authors:  Elias J Jabbour; Jorge E Cortes; Hagop M Kantarjian
Journal:  Expert Rev Anticancer Ther       Date:  2013-12       Impact factor: 4.512

9.  A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia.

Authors:  Janice P Dutcher; Evelyn L Morris; Bruce Gaynor; Elisabeth Paietta; Peter H Wiernik
Journal:  Med Oncol       Date:  2009-08-21       Impact factor: 3.064

Review 10.  Biotherapy of chronic myelogenous leukemia.

Authors:  W E Aulitzky; C Peschel; F Schneller; C Huber
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.